Indeed, our in vitro and in vivo tumorigenic studies clearly show that the ovarian cancer cell growth and cell migration/invasion are remarkably reduced upon treatments of PD98059 or U01260, and Thiostrepton via targeting MEK/ERK and FOXM1 activities respectively. Here, MAP2K7 is linked to ovarian cancer.